Key facts
| Recalling firm | Boston Scientific Neuromodulation Corporation |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | Boston Scientific TCN Electrodes: REF: TCN-5, TCN Electrode, NITINOL, 5 cm x 0.45 mm (0.0175 in); REF:TCN-10, TCN Electrode, NITINOL, 10 cm x 0.45 mm (0.0175 in) REF:TCN-15, TCN Electrode, NITINOL, 15 cm x 0.45 mm (0.0175 in); REF:TCN-20, TCN Electrode, NITINOL, 20 cm x 0.45 mm (0.0175 in) REF: TCN-5-3m, TCN Electrode, NITINOL, 3M CABLE, 5 cm x 0.45 mm (0.0175 in) REF: TCN-10-3M, TCN Electrode, NITINOL, 3M CABLE, 10 cm x 0.45 mm (0.0175 in); REF: TCN-15-3M, TCN Electrode, NITINOL, 3M CABLE, 15 cm x 0.45 mm (0.0175 in) REF: TCN-20-3M, TCN Electrode, NITINOL, 3M CABLE, 20 cm x 0.45 mm (0.0175 in) |
| Classification | Class II |
| Recall number | Z-2403-2026 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | Reusable electrodes may not meet expected performance levels. |
What consumers should do
Because this recall carries FDA's middle severity classification, anyone who has this product should stop using it and follow the recalling firm's instructions, even though serious harm is considered unlikely for this classification. Specifically, check whether the product in your possession matches the description on file with FDA -- Boston Scientific TCN Electrodes: REF: TCN-5, TCN Electrode, NITINOL, 5 cm x 0.45 mm (0.0175 in); REF:TCN-10, TCN Electrode, NITINOL, 10 cm x 0.45 mm (0.0175 in) REF:TCN-15, TCN Electrode, NITINOL, 15 cm x 0.45 mm (0.0175 in); REF:TCN-20, TCN Electrode, NITINOL, 20 cm x 0.45 (additional items listed in FDA's full record) -- and the recall number Z-2403-2026. If it matches, stop using or distributing it and contact Boston Scientific Neuromodulation Corporation or the point of purchase for return or replacement instructions. Retailers and distributors holding affected inventory should quarantine it and follow the firm's written recall notice.
What this classification means
FDA classifies a recall as Class II when using the recalled product, or being exposed to it, may cause temporary or medically reversible adverse health consequences, or when the probability of serious adverse health consequences is remote. In this case, the recalling firm is Boston Scientific Neuromodulation Corporation and the affected product is described in FDA's record as: Boston Scientific TCN Electrodes: REF: TCN-5, TCN Electrode, NITINOL, 5 cm x 0.45 mm (0.0175 in); REF:TCN-10, TCN Electrode, NITINOL, 10 cm x 0.45 mm (0.0175 in) REF:TCN-15, TCN Electrode, NITINOL, 15 cm x 0.45 mm (0.0175 in); REF:TCN-20, TCN Electrode, NITINOL, 20 cm x 0.45 (additional items listed in FDA's full record). FDA's stated reason for the recall is: Reusable electrodes may not meet expected performance levels.. The recall is tracked under FDA recall number Z-2403-2026 and carries a status of Ongoing as of the most recent FDA enforcement report. This classification reflects FDA's assessment of the product defect described above, not a prediction about any specific patient outcome. FDA maintains a public enforcement report database so that consumers, physicians, and purchasers can look up the exact product identifiers involved before deciding what to do. Recall status can change while FDA and the recalling firm continue corrective actions, so checking the firm's own notice for the most current guidance is recommended.
Boston Scientific Neuromodulation Corporation’s FDA history
Argus HQ has recorded 11 total FDA actions tied to Boston Scientific Neuromodulation Corporation: 0 warning letters, 11 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- How serious is this recall?
- FDA classifies a recall as Class II when using the recalled product, or being exposed to it, may cause temporary or medically reversible adverse health consequences, or when the probability of serious adverse health consequences is remote.
- What should someone who has this product do?
- Because this recall carries FDA's middle severity classification, anyone who has this product should stop using it and follow the recalling firm's instructions, even though serious harm is considered unlikely for this classification. Check the product against FDA's description (Boston Scientific TCN Electrodes: REF: TCN-5, TCN Electrode, NITINOL, 5 cm x 0.45 mm (0.0175 in); REF:TCN-10, TCN Electrode, NITINOL, 10 cm x 0.45 mm (0.0175 in) REF:TCN-15, TCN Electrode, NITINOL, 15 cm x 0.45 mm (0.0175 in); REF:TCN-20, TCN Electrode, NITINOL, 20 cm x.
- Has Boston Scientific Neuromodulation Corporation had other FDA recalls or enforcement actions?
- Yes. Argus HQ has recorded 11 total FDA actions tied to Boston Scientific Neuromodulation Corporation, including 11 recalls and 0 warning letters.
- What is the FDA recall number for this event?
- FDA recall number Z-2403-2026.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Boston Scientific Neuromodulation Corporation- Recall: Boston Scientific Neuromodulation Corporation — Class I recall: INFINION CX LEAD KIT, 50CM, Model: SC-2317-50, Material: M365SC2317500; INFINI… →
- Recall: Boston Scientific Neuromodulation Corporation — Class II recall: Intracept Access Instruments, Description/REF: INTRACEPT ACCESS INSTRUMENTS- DR… →
- Recall: Boston Scientific Neuromodulation Corporation — Class II recall: Vercise Deep Brain Stimulation Systems Surgical Implant Manual, Document Number:… →
- Recall: Boston Scientific Neuromodulation Corporation — Class II recall: Superion IDS Kit Superion Indirect Decompression System 8MM, VF Implant 101-98… →
- Recall: Boston Scientific Neuromodulation Corporation — Class II recall: Burr Hole Cover Kit, REF: M365DB4600C0; Burr Hole Cover Spares Kit, REF: M365DB… →
- Recall: Boston Scientific Neuromodulation Corporation — Class II recall: WAVEWRITER ALPHA: Model: SC-1216, 16 IPG KIT, REF: M365SC12160; Model: SC-1232,… →
- Recall: Boston Scientific Neuromodulation Corporation — Class II recall: Vercise Genus Deep Brain Stimulation (DBS) Implantable Pulse Generator IPG: R16… →
- Recall: Boston Scientific Neuromodulation Corporation — Class II recall: Driver Instrument, part of the Superion Indirect Decompression System, REF: 102-… →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Class II Recall: Boston Scientific TCN Electrodes: REF: TCN-5, TCN Electrode,… by Boston Scientific Neuromodulation Corporation. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/recall/fda-recall-boston-scientific-neuromodulation-corporation-z-2403-2026
"FDA Class II Recall: Boston Scientific TCN Electrodes: REF: TCN-5, TCN Electrode,… by Boston Scientific Neuromodulation Corporation." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/recall/fda-recall-boston-scientific-neuromodulation-corporation-z-2403-2026.
Argus HQ Research. "FDA Class II Recall: Boston Scientific TCN Electrodes: REF: TCN-5, TCN Electrode,… by Boston Scientific Neuromodulation Corporation." Digital Empire Holdings LLC. Accessed August 27, 2026. https://argushq.ai/recall/fda-recall-boston-scientific-neuromodulation-corporation-z-2403-2026.
@misc{argushq_argushq_ai_recall_fda_recall_boston_scientific_neuromodulation_corporation_z_2403_2026_2026,
title = {FDA Class II Recall: Boston Scientific TCN Electrodes: REF: TCN-5, TCN Electrode,… by Boston Scientific Neuromodulation Corporation},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/recall/fda-recall-boston-scientific-neuromodulation-corporation-z-2403-2026},
note = {Accessed: August 27, 2026}
}Source: FDA.gov — Recalls ↗

